HEVDUA
LIVE

Serial Number

79305397

Owner

Theravance Biopharma Ireland Limited

Attorney

Beth H. Alter

Filing Date

Dec 30, 2020

Add to watchlist:

No watchlists yet
View on USPTO

HEVDUA Trademark

Serial Number: 79305397 • Registration: 6624377

HEVDUA is a trademark filed by Theravance Biopharma Ireland Limited on December 30, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Theravance Biopharma Ireland Limited (8 trademarks)

10 Earlsfort Terrace,

Entity Type: 99

Trademark Details

Filing Date

December 30, 2020

Registration Date

January 25, 2022

Published for Opposition

November 9, 2021

Goods & Services

Diagnostic preparations and materials, namely, diagnostic preparations for medical and veterinary use; pharmaceutical preparations for treatment of human diseases of the autonomic, respiratory, endocrine, circulatory, gastrointestinal, genito-urinary, integumentary, immune and central nervous system; pharmaceutical preparations for the treatment of cancer and pain; pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations and substances for the treatment of ocular and dermatological diseases and disorders; pharmaceutical preparations and substances for the treatment of neurogenic orthostatic hypotension and for the prevention and treatment of low blood pressure; pharmaceutical preparations and substances in the nature of anti-hypotensive and vasopressor agents; pharmaceutical preparations and substances for the treatment of Parkinson's disease and disorders; pharmaceutical preparations and substances for the prevention and treatment of dizziness and lightheadedness; pharmaceutical preparations and substances for the treatment of disorders characterized by a deficiency of norepinephrine; pharmaceutical preparations and substances for the treatment of bacterial and viral infections, namely anti-infectives

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 23, 2023 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 1, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 7, 2022 FICS
FINAL DISPOSITION PROCESSED
Jul 7, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 25, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 25, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 9, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 9, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 20, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 4, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 1, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 1, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 1, 2021 TROA
REFUSAL PROCESSED BY IB
Aug 15, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 28, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jul 28, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 19, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jul 18, 2021 CNRT
ASSIGNED TO EXAMINER
Jul 3, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 9, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 5, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 4, 2021 REPR